Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Nanexa | NANEXA | 1. avr 2025 | 1.16 | +4.05 |
NanoCap Group B | NANOCB | 1. avr 2025 | 5.18 | -10.07 |
NanoEcho | NANECH | 1. avr 2025 | 0.11 | -5.44 |
Nanoform Finland | NANOFS | 1. avr 2025 | 13.02 | -2.54 |
Nanologica | NICA | 1. avr 2025 | 1.27 | -1.54 |
NASDAQ OMX Small Cap Sweden GI | NOMXSCSEGI | 1. avr 2025 | 4 260.05 | +1.69 |
NASDAQ OMX Small Cap Sweden PI | NOMXSCSE | 1. avr 2025 | 2 620.80 | +1.69 |
Nattaro Labs | NATTA | 1. avr 2025 | 0.35 | 0.00 |
Navigo Invest AB | NAVIGOSTAM | 1. avr 2025 | 1.99 | +0.76 |
Navigo Invest Pref | NAVIGOPREF | 1. avr 2025 | 92.00 | -0.86 |
NAXS | NAXS | 1. avr 2025 | 57.20 | +2.14 |
NCAB Group | NCAB | 1. avr 2025 | 52.40 | +2.04 |
NCC A | NCCA | 1. avr 2025 | 193.50 | +1.31 |
NCC B | NCCB | 1. avr 2025 | 192.50 | +1.26 |
Nederman Holding | NMAN | 1. avr 2025 | 204.50 | -2.62 |
NEL | NELO | 1. avr 2025 | 2.46 | +4.68 |
Nelly Group | NELLY | 1. avr 2025 | 33.35 | -0.89 |
Neobo Fastigheter | NEOBO | 1. avr 2025 | 15.62 | +2.23 |
Neola Medical | NEOLA | 1. avr 2025 | 2.72 | +0.74 |
Neovici Holding B | NEOB | 1. avr 2025 | 7.40 | +4.67 |
Nepa | NEPA | 1. avr 2025 | 21.10 | 0.00 |
Net Insight B | NETIB | 1. avr 2025 | 4.64 | +0.22 |
Netel | NETEL | 1. avr 2025 | 10.96 | -4.53 |
NetJobs Group | NJOB | 1. avr 2025 | 0.57 | -3.39 |
New Nordic Healthbrands | NNH | 1. avr 2025 | 13.70 | -1.44 |
New Wave B | NEWAB | 1. avr 2025 | 101.40 | +1.76 |
Newbury Pharmaceuticals | NEWBRY | 1. avr 2025 | 3.27 | +1.55 |
Nexam Chemical Holding | NEXAM | 1. avr 2025 | 3.20 | +4.23 |
Nexar Group | NXAR | 1. avr 2025 | 0.69 | -1.44 |
NextCell Pharma AB | NXTCL | 1. avr 2025 | 2.88 | +2.86 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.